PREVALENCE OF SHORT STATURE IN PEDIATRIC β -THALASSEMIA MAJOR PATIENTS ADMITTED TO A TERTIARY CARE CENTER

Mohit Upadhye, Dr. Asha P. T., Dr. Aarti Kinikar

Abstract


Background: Growth failure is an important complication of β-Thalassemia major in pediatric patients.
Aims and objectives: To estimate the prevalence of short stature in the pediatric patients of β-thalassemia major.
Materials and methods: 122 β-thalassemia major patients between 1 to 12 years of age, receiving regular blood transfusions with or without iron
chelation therapy were enrolled in this record based study. The data was analyzed using WHO growth standards.
Results: 34.43% of the patients were of short stature. 59.52% of the short stature patients were underweight. The maximum number of short stature
patients was seen in the age group of 11 to 12 years.
Conclusion: The prevalence of short stature in β-thalassemia major is 34.43%. Patients in the age group of 11 to 12 years seem to be most affected.
Malnutrition is more prevalent in short stature than in normal stature thalassemia patients.


Keywords


Growth failure, Prevalence, Short stature, Thalassemia

Full Text:

PDF

References


Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010 May 21;5:11.

Harteveld CL, Higgs DR. α-thalassaemia. Orphanet J Rare Dis. 2010 May 28;5(1):13.

Nienhuis AW, Nathan DG. Pathophysiology and Clinical Manifestations of the β-Thalassemias. Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a011726.

Skordis N, Kyriakou A. The multifactorial origin of growth failure in thalassaemia. Pediatr Endocrinol Rev. 2011 Mar;8 Suppl 2:271–7.

Growth Charts - Clinical Growth Charts [Internet]. Centres for Disease Control and Prevention, National Center for Health Statistics. 2017 [cited 2018 Apr 28]. Available from: https://www.cdc.gov/growthcharts/clinical_charts.htm

Zlotkin D, Varma SK. Psychosocial effects of short stature. Indian J Pediatr [Internet]. 2006 Jan [cited 2018 Aug 16];73(1):79–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16444067

De Sanctis V, Soliman AT, Elsedfy H, Skordis N, Kattamis C, Angastiniotis M, et al. Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines. Indian J Endocrinol Metab. 2013 Jan;17(1):8–18.

Kyriakou A, Skordis N. Thalassaemia and aberrations of growth and puberty. Mediterr J Hematol Infect Dis [Internet]. 2009 Jul 27 [cited 2018 Aug 16];1(1):e2009003. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21415985

Theodoridis C, Ladis V, Papatheodorou A, Berdousi H, Palamidou F, Evagelopoulou C, et al. Growth and management of short stature in thalassaemia major. J Pediatr Endocrinol Metab. 1998;11 Suppl 3:835–44.

Kumari Vasundhara, Upadhyay SK, Gupta Vineeta, Piplani K Satya BB. Growth retardation and malnutrition in children with thalassemia major. Indian J Prev Soc Med [Internet]. 2012 [cited 2018 Aug 16];43(2):149–52. Available from: http://medind.nic.in/ibl/t12/i2/iblt12i2p149.pdf


Refbacks

  • There are currently no refbacks.